Nektar Therapeutics (LON:0UNL)
London · Delayed Price · Currency is GBP · Price in USD 51.28
+1.66 (3.35%)
At close: Sep 17, 2025
Nektar Therapeutics Market Cap
Nektar Therapeutics has a market cap or net worth of 695.26 million as of September 17, 2025. Its market cap has increased by 287.76% in one year.
Market Cap
695.26M
Enterprise Value
695.87M
Revenue
54.69M
Ranking
n/a
PE Ratio
n/a
Stock Price
51.28
Market Cap Chart
Since May 3, 1994, Nektar Therapeutics's market cap has increased from 42.81M to 695.26M, an increase of 1,523.91%. That is a compound annual growth rate of 9.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2025 | 710.94M | 418.83% |
| Dec 31, 2024 | 137.03M | 61.93% |
| Dec 29, 2023 | 84.62M | -76.00% |
| Dec 30, 2022 | 352.54M | -80.85% |
| Dec 31, 2021 | 1.84B | -17.57% |
| Dec 31, 2020 | 2.23B | -22.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 182.89B |
| GSK plc | 59.54B |
| Haleon | 31.92B |
| Smith & Nephew | 12.02B |
| ConvaTec Group | 4.70B |
| Hikma Pharmaceuticals | 3.56B |
| HUTCHMED (China) | 2.23B |
| Genus | 1.65B |